A Study to Describe the Effectiveness and Safety of Venetoclax Treatment in Chronic Lymphocytic Leukemia (CLL) Patients in Routine Clinical Practice

NCT03659669 · clinicaltrials.gov ↗
SUSPENDED
Status
272
Enrollment
INDUSTRY
Sponsor class

Stopped Strategic considerations

Conditions

Sponsor

AbbVie